Heterogeneous dysregulation of microRNAs across the autism spectrum.

Fragile X syndrome: loss of local mRNA regulation alters synaptic development and function. Neuron (2008) 6.26

Oxytocin: the great facilitator of life. Prog Neurobiol (2009) 3.71

Identification of a microRNA that activates gene expression by repressing nonsense-mediated RNA decay. Mol Cell (2011) 2.73

Reversible inhibition of PSD-95 mRNA translation by miR-125a, FMRP phosphorylation, and mGluR signaling. Mol Cell (2011) 2.27

Cooperative and individualistic functions of the microRNAs in the miR-23a~27a~24-2 cluster and its implication in human diseases. Mol Cancer (2010) 2.14

MicroRNAs in neuronal function and dysfunction. Trends Neurosci (2012) 1.94

Reduced excitatory neurotransmission and mild autism-relevant phenotypes in adolescent Shank3 null mutant mice. J Neurosci (2012) 1.71

MicroRNA expression profiling in the prefrontal cortex of individuals affected with schizophrenia and bipolar disorders. Schizophr Res (2010) 1.61

Sociability and motor functions in Shank1 mutant mice. Brain Res (2010) 1.60

Epigenetic principles and mechanisms underlying nervous system functions in health and disease. Prog Neurobiol (2008) 1.53

Gene expression profiling differentiates autism case-controls and phenotypic variants of autism spectrum disorders: evidence for circadian rhythm dysfunction in severe autism. Autism Res (2009) 1.53

microRNA regulation of synaptic plasticity. Neuromolecular Med (2009) 1.49

MicroRNA expression aberration as potential peripheral blood biomarkers for schizophrenia. PLoS One (2011) 1.47

Copy number variable microRNAs in schizophrenia and their neurodevelopmental gene targets. Biol Psychiatry (2014) 1.46

Investigation of post-transcriptional gene regulatory networks associated with autism spectrum disorders by microRNA expression profiling of lymphoblastoid cell lines. Genome Med (2010) 1.41

Prevalence of SHANK3 variants in patients with different subtypes of autism spectrum disorders. Eur J Hum Genet (2012) 1.36

Aberrant expression of long noncoding RNAs in autistic brain. J Mol Neurosci (2012) 1.30

Functions of noncoding RNAs in neural development and neurological diseases. Mol Neurobiol (2011) 1.27

MicroRNA networks direct neuronal development and plasticity. Cell Mol Life Sci (2011) 1.23

General principals of miRNA biogenesis and regulation in the brain. Neuropsychopharmacology (2012) 1.23

The Emerging Role of microRNAs in Schizophrenia and Autism Spectrum Disorders. Front Psychiatry (2012) 1.22

MicroRNAs in psychiatric and neurodevelopmental disorders. Brain Res (2010) 1.22

Feasibility and relevance of examining lymphoblastoid cell lines to study role of microRNAs in autism. Autism Res (2008) 1.21

Autism Genetic Database (AGD): a comprehensive database including autism susceptibility gene-CNVs integrated with known noncoding RNAs and fragile sites. BMC Med Genet (2009) 1.11

Epigenetic mechanisms underlying human epileptic disorders and the process of epileptogenesis. Neurobiol Dis (2010) 1.11

Nonsense-mediated decay in genetic disease: friend or foe? Mutat Res Rev Mutat Res (2014) 1.10

Characteristics and predictive value of blood transcriptome signature in males with autism spectrum disorders. PLoS One (2012) 1.09

Serum microRNA profiles in children with autism. Mol Autism (2014) 1.08

Big effects of small RNAs: a review of microRNAs in anxiety. Mol Neurobiol (2012) 1.04

MicroRNA dysregulation in neuropsychiatric disorders and cognitive dysfunction. Neurobiol Dis (2012) 1.02

MicroRNA and messenger RNA profiling reveals new biomarkers and mechanisms for RDX induced neurotoxicity. BMC Genomics (2014) 1.02

A direct molecular link between the autism candidate gene RORa and the schizophrenia candidate MIR137. Sci Rep (2014) 1.00

Neuronal activity regulates hippocampal miRNA expression. PLoS One (2011) 0.98

The Path to microRNA Therapeutics in Psychiatric and Neurodegenerative Disorders. Front Genet (2012) 0.98

Insights on the functional impact of microRNAs present in autism-associated copy number variants. PLoS One (2013) 0.97

Short non-coding RNA biology and neurodegenerative disorders: novel disease targets and therapeutics. Hum Mol Genet (2009) 0.97

Small regulatory RNAs in neurodevelopmental disorders. Hum Mol Genet (2009) 0.96

Brain microRNAs and insights into biological functions and therapeutic potential of brain enriched miRNA-128. Mol Cancer (2014) 0.96

Mood stabilizer-regulated miRNAs in neuropsychiatric and neurodegenerative diseases: identifying associations and functions. Am J Transl Res (2013) 0.92

Gene expression analysis in lymphoblasts derived from patients with autism spectrum disorder. Mol Autism (2011) 0.92

MicroRNA-mediated dysregulation of neural developmental genes in HPRT deficiency: clues for Lesch-Nyhan disease? Hum Mol Genet (2011) 0.91

MicroRNAs: Key Regulators in the Central Nervous System and Their Implication in Neurological Diseases. Int J Mol Sci (2016) 0.87

Molecular mechanisms of peripheral nerve regeneration: emerging roles of microRNAs. Front Physiol (2013) 0.86

Atypical miRNA expression in temporal cortex associated with dysregulation of immune, cell cycle, and other pathways in autism spectrum disorders. Mol Autism (2015) 0.86

MicroRNA Profiling of Neurons Generated Using Induced Pluripotent Stem Cells Derived from Patients with Schizophrenia and Schizoaffective Disorder, and 22q11.2 Del. PLoS One (2015) 0.86

AKAPs integrate genetic findings for autism spectrum disorders. Transl Psychiatry (2013) 0.85

Heterogeneity and individuality: microRNAs in mental disorders. J Neural Transm (Vienna) (2014) 0.84

A conserved microRNA/NMD regulatory circuit controls gene expression. RNA Biol (2012) 0.84

MicroRNAs: Not "Fine-Tuners" but Key Regulators of Neuronal Development and Function. Front Neurol (2015) 0.83

Mining the 3'UTR of autism-implicated genes for SNPs perturbing microRNA regulation. Genomics Proteomics Bioinformatics (2014) 0.83

From genes to environment: using integrative genomics to build a "systems-level" understanding of autism spectrum disorders. Child Dev (2012) 0.81

Environmental exposures in utero and microRNA. Curr Opin Pediatr (2014) 0.81

Genetic variants of neurotransmitter-related genes and miRNAs in Egyptian autistic patients. ScientificWorldJournal (2013) 0.80

Profiling olfactory stem cells from living patients identifies miRNAs relevant for autism pathophysiology. Mol Autism (2016) 0.80

Specific Regional and Age-Related Small Noncoding RNA Expression Patterns Within Superior Temporal Gyrus of Typical Human Brains Are Less Distinct in Autism Brains. J Child Neurol (2015) 0.80

Assessing the impact of copy number variants on miRNA genes in autism by Monte Carlo simulation. PLoS One (2014) 0.79

Investigation of Gene Regulatory Networks Associated with Autism Spectrum Disorder Based on MiRNA Expression in China. PLoS One (2015) 0.79

Salivary miRNA profiles identify children with autism spectrum disorder, correlate with adaptive behavior, and implicate ASD candidate genes involved in neurodevelopment. BMC Pediatr (2016) 0.78

Hypomethylation of miR-142 promoter and upregulation of microRNAs that target the oxytocin receptor gene in the autism prefrontal cortex. Mol Autism (2015) 0.78

The evolutionary pattern and the regulation of stearoyl-CoA desaturase genes. Biomed Res Int (2013) 0.77

The expanding genomic landscape of autism: discovering the 'forest' beyond the 'trees' Future Neurol (2013) 0.77

MiRNA-128 regulates the proliferation and neurogenesis of neural precursors by targeting PCM1 in the developing cortex. Elife (2016) 0.77

Multiple microRNAs regulate human FOXP2 gene expression by targeting sequences in its 3' untranslated region. Mol Brain (2014) 0.77

miRNA profiling in autism spectrum disorder in China. Genom Data (2015) 0.76

Functional genomics of human brain development and implications for autism spectrum disorders. Transl Psychiatry (2015) 0.76

Common microRNAs Target Established ASD Genes. Front Neurol (2014) 0.76

Turing Revisited: Decoding the microRNA Messages in Brain Extracellular Vesicles for Early Detection of Neurodevelopmental Disorders. Curr Environ Health Rep (2016) 0.75

Fluoxetine Increases the Expression of miR-572 and miR-663a in Human Neuroblastoma Cell Lines. PLoS One (2016) 0.75

MIR137 is the key gene mediator of the syndromic obesity phenotype of patients with 1p21.3 microdeletions. Mol Cytogenet (2016) 0.75

Comment on the article "Heterogeneous dysregulation of microRNAs across the autism spectrum" by Abu-Elneel et al. Neurogenetics (2009) 0.75

Knowledge-Guided Bioinformatics Model for Identifying Autism Spectrum Disorder Diagnostic MicroRNA Biomarkers. Sci Rep (2016) 0.75

MicroRNA 433 regulates nonsense-mediated mRNA decay by targeting SMG5 mRNA. BMC Mol Biol (2016) 0.75

A Comparative Review of microRNA Expression Patterns in Autism Spectrum Disorder. Front Psychiatry (2016) 0.75

Microribonucleic acid dysregulations in children and adolescents with obsessive-compulsive disorder. Neuropsychiatr Dis Treat (2015) 0.75

The miR-132/212 locus: a complex regulator of neuronal plasticity, gene expression and cognition. RNA Dis (2016) 0.75

The Role of MicroRNAs in Cerebellar Development and Autism Spectrum Disorder During Embryogenesis. Mol Neurobiol (2016) 0.75

Global variation in copy number in the human genome. Nature (2006) 57.50

Strong association of de novo copy number mutations with autism. Science (2007) 27.84

Comprehensive human genetic maps: individual and sex-specific variation in recombination. Am J Hum Genet (1998) 19.35

Structural variation of chromosomes in autism spectrum disorder. Am J Hum Genet (2008) 15.51

Mutations of the X-linked genes encoding neuroligins NLGN3 and NLGN4 are associated with autism. Nat Genet (2003) 15.31

Model-based analysis of oligonucleotide arrays: model validation, design issues and standard error application. Genome Biol (2001) 15.02

Mapping autism risk loci using genetic linkage and chromosomal rearrangements. Nat Genet (2007) 14.05

Mutations in the gene encoding the synaptic scaffolding protein SHANK3 are associated with autism spectrum disorders. Nat Genet (2006) 11.14

Linkage disequilibrium and heritability of copy-number polymorphisms within duplicated regions of the human genome. Am J Hum Genet (2006) 7.70

Identification of novel autism candidate regions through analysis of reported cytogenetic abnormalities associated with autism. Mol Psychiatry (2006) 5.63

The neuronal microRNA system. Nat Rev Neurosci (2006) 5.38

Recessive symptomatic focal epilepsy and mutant contactin-associated protein-like 2. N Engl J Med (2006) 5.28

X-linked mental retardation and autism are associated with a mutation in the NLGN4 gene, a member of the neuroligin family. Am J Hum Genet (2004) 5.15

Contribution of SHANK3 mutations to autism spectrum disorder. Am J Hum Genet (2007) 5.04

Prevalence of autism spectrum disorders--autism and developmental disabilities monitoring network, 14 sites, United States, 2002. MMWR Surveill Summ (2007) 4.70

Autism or atypical autism in maternally but not paternally derived proximal 15q duplication. Am J Hum Genet (1997) 3.95

The genetics of autistic disorders and its clinical relevance: a review of the literature. Mol Psychiatry (2006) 3.63

A clinicopathological study of autism. Brain (1998) 3.49

microRNA expression in the prefrontal cortex of individuals with schizophrenia and schizoaffective disorder. Genome Biol (2007) 3.26

Neuroanatomic observations of the brain in autism: a review and future directions. Int J Dev Neurosci (2005) 3.01

The Arg451Cys-neuroligin-3 mutation associated with autism reveals a defect in protein processing. J Neurosci (2004) 2.66

The neurobiology of autism. Brain Pathol (2007) 2.63

Genetics of autism spectrum disorder. Eur J Hum Genet (2006) 2.24

Recent advances in the genetics of autism. Biol Psychiatry (2006) 2.11

Association of tuberous sclerosis of temporal lobes with autism and atypical autism. Lancet (1997) 1.83

Neuro-epileptic determinants of autism spectrum disorders in tuberous sclerosis complex. Brain (2002) 1.75

Multiplexing RT-PCR for the detection of multiple miRNA species in small samples. Biochem Biophys Res Commun (2006) 1.69

Brain overgrowth in autism during a critical time in development: implications for frontal pyramidal neuron and interneuron development and connectivity. Int J Dev Neurosci (2005) 1.65

The contribution of neuropathologic studies to the understanding of autism. Neurol Clin (1993) 1.57

Behavior phenotype in the RSH/Smith-Lemli-Opitz syndrome. Am J Med Genet (2001) 1.55

Brain development in autism: early overgrowth followed by premature arrest of growth. Ment Retard Dev Disabil Res Rev (2004) 1.52

Evidence for multiple loci from a genome scan of autism kindreds. Mol Psychiatry (2006) 1.52

Detection of a microRNA signal in an in vivo expression set of mRNAs. PLoS One (2007) 1.40

The near universal presence of autism spectrum disorders in children with Smith-Lemli-Opitz syndrome. Am J Med Genet A (2006) 1.37

A review of gene linkage, association and expression studies in autism and an assessment of convergent evidence. Int J Dev Neurosci (2006) 1.30

Spatial attention deficits in patients with acquired or developmental cerebellar abnormality. J Neurosci (1999) 1.23

Genotype and psychological phenotype in tuberous sclerosis. J Med Genet (2004) 1.18

A genome-wide search for alleles and haplotypes associated with autism and related pervasive developmental disorders on the Faroe Islands. Mol Psychiatry (2006) 1.13

The neuropathology of the autism spectrum disorders: what have we learned? Novartis Found Symp (2003) 1.12

Autism: the quest for the genes. Expert Rev Mol Med (2007) 1.10

Quantitative trait locus analysis of nonverbal communication in autism spectrum disorder. Mol Psychiatry (2006) 1.05

The fragile X gene and its function. Clin Genet (2001) 1.01

Autism spectrum disorders: molecular genetic advances. Am J Med Genet C Semin Med Genet (2006) 0.90

Purkinje cell vulnerability and autism: a possible etiological connection. Brain Dev (2003) 0.89

Molecular genetic analysis of the FMR-1 gene in a large collection of autistic patients. Hum Genet (1997) 0.89

Rett syndrome: clinical and molecular update. Curr Opin Pediatr (2004) 0.88

Neuropsychological, psychiatric, and physical manifestations in 149 members from 18 fragile X families. Am J Med Genet (1991) 0.87

Neuroanatomic imaging in autism. Pediatrics (1991) 0.82

Genetics of childhood disorders: XLVIII. Learning and memory, Part 1: Fragile X syndrome update. J Am Acad Child Adolesc Psychiatry (2003) 0.78

Association and transmission analysis of the FMR1 IVS10 + 14C-T variant in autism. Am J Med Genet B Neuropsychiatr Genet (2004) 0.77

Strong association of de novo copy number mutations with autism. Science (2007) 27.84

Expanded GGGGCC hexanucleotide repeat in noncoding region of C9ORF72 causes chromosome 9p-linked FTD and ALS. Neuron (2011) 20.15

MicroRNA-21 is an antiapoptotic factor in human glioblastoma cells. Cancer Res (2005) 18.58

Functional impact of global rare copy number variation in autism spectrum disorders. Nature (2010) 14.66

Mapping autism risk loci using genetic linkage and chromosomal rearrangements. Nat Genet (2007) 14.05

De novo mutations revealed by whole-exome sequencing are strongly associated with autism. Nature (2012) 13.61

Advances in autism genetics: on the threshold of a new neurobiology. Nat Rev Genet (2008) 12.18

mRNA-Seq whole-transcriptome analysis of a single cell. Nat Methods (2009) 11.71

Cancerous stem cells can arise from pediatric brain tumors. Proc Natl Acad Sci U S A (2003) 10.56

Transcriptomic analysis of autistic brain reveals convergent molecular pathology. Nature (2011) 10.16

Common variants at MS4A4/MS4A6E, CD2AP, CD33 and EPHA1 are associated with late-onset Alzheimer's disease. Nat Genet (2011) 10.07

A microRNA array reveals extensive regulation of microRNAs during brain development. RNA (2003) 9.76

Downregulation of miRNA-200c links breast cancer stem cells with normal stem cells. Cell (2009) 8.33

MicroRNA-145 regulates OCT4, SOX2, and KLF4 and represses pluripotency in human embryonic stem cells. Cell (2009) 8.14

Genetic relationship between five psychiatric disorders estimated from genome-wide SNPs. Nat Genet (2013) 8.02

Identification of many microRNAs that copurify with polyribosomes in mammalian neurons. Proc Natl Acad Sci U S A (2003) 7.95

Common genetic variants on 5p14.1 associate with autism spectrum disorders. Nature (2009) 7.39

Probing gene expression in live cells, one protein molecule at a time. Science (2006) 7.21

Linkage, association, and gene-expression analyses identify CNTNAP2 as an autism-susceptibility gene. Am J Hum Genet (2008) 7.13

Functional organization of the transcriptome in human brain. Nat Neurosci (2008) 7.02

Specific microRNAs modulate embryonic stem cell-derived neurogenesis. Stem Cells (2005) 6.72

Conservation and evolution of gene coexpression networks in human and chimpanzee brains. Proc Natl Acad Sci U S A (2006) 5.69

Functional and evolutionary insights into human brain development through global transcriptome analysis. Neuron (2009) 5.46

Molecular cytogenetic analysis and resequencing of contactin associated protein-like 2 in autism spectrum disorders. Am J Hum Genet (2008) 5.44

The Amphimedon queenslandica genome and the evolution of animal complexity. Nature (2010) 5.11

A functional genetic link between distinct developmental language disorders. N Engl J Med (2008) 4.99

Tracing the derivation of embryonic stem cells from the inner cell mass by single-cell RNA-Seq analysis. Cell Stem Cell (2010) 4.97

MicroRNA profiling of the murine hematopoietic system. Genome Biol (2005) 4.94

Elevated gene expression levels distinguish human from non-human primate brains. Proc Natl Acad Sci U S A (2003) 4.69

Absence of CNTNAP2 leads to epilepsy, neuronal migration abnormalities, and core autism-related deficits. Cell (2011) 4.58

The role of selection in the evolution of human mitochondrial genomes. Genetics (2005) 4.56

RNA-Seq analysis to capture the transcriptome landscape of a single cell. Nat Protoc (2010) 4.35

Maternal microRNAs are essential for mouse zygotic development. Genes Dev (2007) 4.16

Single-cell RNA-Seq profiling of human preimplantation embryos and embryonic stem cells. Nat Struct Mol Biol (2013) 4.04

FACS-array profiling of striatal projection neuron subtypes in juvenile and adult mouse brains. Nat Neurosci (2006) 3.81

MicroRNA-21 targets a network of key tumor-suppressive pathways in glioblastoma cells. Cancer Res (2008) 3.70

Novel mutations in TARDBP (TDP-43) in patients with familial amyotrophic lateral sclerosis. PLoS Genet (2008) 3.66

Using iPSC-derived neurons to uncover cellular phenotypes associated with Timothy syndrome. Nat Med (2011) 3.66

Brain imaging and fluid biomarker analysis in young adults at genetic risk for autosomal dominant Alzheimer's disease in the presenilin 1 E280A kindred: a case-control study. Lancet Neurol (2012) 3.48

A unified genetic theory for sporadic and inherited autism. Proc Natl Acad Sci U S A (2007) 3.47

A genome-wide scan for common alleles affecting risk for autism. Hum Mol Genet (2010) 3.42

Genome-wide analyses of exonic copy number variants in a family-based study point to novel autism susceptibility genes. PLoS Genet (2009) 3.42

MicroRNA expression profiling of single whole embryonic stem cells. Nucleic Acids Res (2006) 3.36

Roundup: a multi-genome repository of orthologs and evolutionary distances. Bioinformatics (2006) 3.28

Cytogenetic and molecular characterization of A2BP1/FOX1 as a candidate gene for autism. Am J Med Genet B Neuropsychiatr Genet (2007) 3.11

Mutations in a human ROBO gene disrupt hindbrain axon pathway crossing and morphogenesis. Science (2004) 3.01

A systems level analysis of transcriptional changes in Alzheimer's disease and normal aging. J Neurosci (2008) 2.97

PTEN negatively regulates neural stem cell self-renewal by modulating G0-G1 cell cycle entry. Proc Natl Acad Sci U S A (2005) 2.93

Parallel FoxP1 and FoxP2 expression in songbird and human brain predicts functional interaction. J Neurosci (2004) 2.89

Integrative functional genomic analyses implicate specific molecular pathways and circuits in autism. Cell (2013) 2.87

Divergence of human and mouse brain transcriptome highlights Alzheimer disease pathways. Proc Natl Acad Sci U S A (2010) 2.85

MicroRNA biogenesis is required for mouse primordial germ cell development and spermatogenesis. PLoS One (2008) 2.82

Human-specific transcriptional networks in the brain. Neuron (2012) 2.80

Alzheimer's Prevention Initiative: a plan to accelerate the evaluation of presymptomatic treatments. J Alzheimers Dis (2011) 2.78

Apolipoprotein Eepsilon4 modifies Alzheimer's disease onset in an E280A PS1 kindred. Ann Neurol (2003) 2.72

Florbetapir PET analysis of amyloid-β deposition in the presenilin 1 E280A autosomal dominant Alzheimer's disease kindred: a cross-sectional study. Lancet Neurol (2012) 2.65

Development and applications of single-cell transcriptome analysis. Nat Methods (2011) 2.62

Mutations in the gene encoding PDGF-B cause brain calcifications in humans and mice. Nat Genet (2013) 2.62

Early asymmetry of gene transcription in embryonic human left and right cerebral cortex. Science (2005) 2.56

Genome-wide expression profiling of lymphoblastoid cell lines distinguishes different forms of autism and reveals shared pathways. Hum Mol Genet (2007) 2.55

A genomewide screen of 345 families for autism-susceptibility loci. Am J Hum Genet (2003) 2.51

Individual common variants exert weak effects on the risk for autism spectrum disorderspi. Hum Mol Genet (2012) 2.46

Transcriptional architecture of the primate neocortex. Neuron (2012) 2.42

Human brain evolution: insights from microarrays. Nat Rev Genet (2004) 2.42

Multiple chronic pain states are associated with a common amino acid-changing allele in KCNS1. Brain (2010) 2.41

A simple dependence between protein evolution rate and the number of protein-protein interactions. BMC Evol Biol (2003) 2.38

The HDAC inhibitor 4b ameliorates the disease phenotype and transcriptional abnormalities in Huntington's disease transgenic mice. Proc Natl Acad Sci U S A (2008) 2.37

Human-specific transcriptional regulation of CNS development genes by FOXP2. Nature (2009) 2.33

Evidence for a language quantitative trait locus on chromosome 7q in multiplex autism families. Am J Hum Genet (2001) 2.29

Human wild-type tau interacts with wingless pathway components and produces neurofibrillary pathology in Drosophila. Neuron (2002) 2.28

CHIP-Hsc70 complex ubiquitinates phosphorylated tau and enhances cell survival. J Biol Chem (2003) 2.27

MicroRNAs potentiate neural development. Neuron (2009) 2.25

Evidence for sex-specific risk alleles in autism spectrum disorder. Am J Hum Genet (2004) 2.24

Mutations in SLC20A2 are a major cause of familial idiopathic basal ganglia calcification. Neurogenetics (2013) 2.11

Sex differences in autism spectrum disorders. Curr Opin Neurol (2013) 2.11

A quantitative trait locus analysis of social responsiveness in multiplex autism families. Am J Psychiatry (2007) 2.09

Identification of the transcriptional targets of FOXP2, a gene linked to speech and language, in developing human brain. Am J Hum Genet (2007) 2.08

Novel late-onset Alzheimer disease loci variants associate with brain gene expression. Neurology (2012) 2.08

HDAC inhibitors correct frataxin deficiency in a Friedreich ataxia mouse model. PLoS One (2008) 2.08

An evaluation of tyramide signal amplification and archived fixed and frozen tissue in microarray gene expression analysis. Nucleic Acids Res (2002) 2.06

Identification of process-localized mRNAs from cultured rodent hippocampal neurons. J Neurosci (2006) 2.02

Somatodendritic microRNAs identified by laser capture and multiplex RT-PCR. RNA (2007) 2.01

High-throughput analysis of promoter occupancy reveals direct neural targets of FOXP2, a gene mutated in speech and language disorders. Am J Hum Genet (2007) 2.01

Maternal embryonic leucine zipper kinase is a key regulator of the proliferation of malignant brain tumors, including brain tumor stem cells. J Neurosci Res (2008) 1.96

Strategies for aggregating gene expression data: the collapseRows R function. BMC Bioinformatics (2011) 1.96

Coevolution of gene expression among interacting proteins. Proc Natl Acad Sci U S A (2004) 1.96

A post-synaptic scaffold at the origin of the animal kingdom. PLoS One (2007) 1.96

A coordinated local translational control point at the synapse involving relief from silencing and MOV10 degradation. Neuron (2009) 1.96

X-linked protocadherin 19 mutations cause female-limited epilepsy and cognitive impairment. Nat Genet (2008) 1.95

An age-related sprouting transcriptome provides molecular control of axonal sprouting after stroke. Nat Neurosci (2010) 1.89

Suberoylanilide hydroxamic acid (vorinostat) up-regulates progranulin transcription: rational therapeutic approach to frontotemporal dementia. J Biol Chem (2011) 1.88

220-plex microRNA expression profile of a single cell. Nat Protoc (2006) 1.88

ATF4 is an oxidative stress-inducible, prodeath transcription factor in neurons in vitro and in vivo. J Exp Med (2008) 1.86

Functional genomic analysis of frataxin deficiency reveals tissue-specific alterations and identifies the PPARgamma pathway as a therapeutic target in Friedreich's ataxia. Hum Mol Genet (2009) 1.85

A common X-linked inborn error of carnitine biosynthesis may be a risk factor for nondysmorphic autism. Proc Natl Acad Sci U S A (2012) 1.85

Deterministic and stochastic allele specific gene expression in single mouse blastomeres. PLoS One (2011) 1.82

Deletion of the neuron-specific protein delta-catenin leads to severe cognitive and synaptic dysfunction. Curr Biol (2004) 1.80

Biomedical cloud computing with Amazon Web Services. PLoS Comput Biol (2011) 1.79